Smilegate Investment, established in 1999 in Seoul, South Korea, is a venture capital and private equity firm that has actively supported the growth of over 200 companies since its inception. Originally founded as MVP Capital, the firm has organized and managed more than 30 funds, focusing on a diverse range of sectors including B2B, B2C, media, healthcare, energy, information technology, advanced manufacturing, climate technology, digital health, SaaS, artificial intelligence, big data, e-commerce, financial technology, mobile commerce, clean technology, and life sciences. Smilegate Investment aims to identify and nurture promising growth potential within these industries, contributing to the advancement of the South Korean economy.
The company is a spin-off from Asan Medical Center, University of Ulsan University, with a primary objective of developing therapeutic and diagnostic agents for neurological diseases, particularly Alzheimer's disease. In 2016, the company took significant steps toward formalizing its presence in the market by completing its incorporation and business registration processes. The year 2017 proved to be a milestone for the company as it obtained certification as a corporate-affiliated research institute, solidifying its position as a reputable research-driven organization. Additionally, it garnered recognition as a leading university start-up by the Ministry of SMEs and Startups, further boosting its credibility and potential for growth. The company has collaborated with Oscotech Co., Ltd. and partnered with various investors, including Kite Entrepreneurship Foundation, Stone Bridge Ventures Co., Ltd., Korea Development Bank, and Stick Ventures Co., Ltd., to jointly develop their projects.
CastingN
Series B in 2024
CastingN Co., Ltd is an online sourcing platform based in Incheon, South Korea, established in 2015. It connects companies with professional subcontractors across various sectors, facilitating the outsourcing of services such as advertising, system development, web design, and accounting. The platform evaluates multiple factors, including company history, performance, and feedback, to identify the most suitable subcontractors for clients' needs. In addition to its matching services, CastingN offers programs for developing job-oriented content and conducting offline job training, enabling companies to work efficiently with specialized service providers.
Habit Factory
Series C in 2023
Habit Factory is a South Korea-based company that specializes in developing application software aimed at analyzing users' consumption patterns. By providing insights into spending habits, the company helps individuals understand their financial behavior and enhance their savings. Additionally, Habit Factory offers financial big data analytics solutions and has created a platform that simplifies the search for insurance policies using basic information such as a phone number or credit card. This platform not only analyzes users' financial data but also delivers personalized information and recommendations, thereby facilitating informed decision-making in financial services.
Bosalpim
Seed Round in 2022
Bosalpim is a supplier of visiting care brokerage services for the elderly. Headquartered in Gangnam-gu, Seoul.
G+FLAS Life Sciences
Series E in 2022
G+FLAS Life Sciences Co., Ltd., founded in 2014 and based in Seoul, South Korea, specializes in agricultural biotechnology with a focus on genome editing applications. Utilizing advanced CRISPR-Cas technology, the company develops innovative products such as glycoengineered humanized plants, which involve the selective removal of glycosylation-related genes. A flagship product is the vitamin D3-enriched tomato, aimed at enhancing nutritional value and addressing market demand for functional foods. This product not only serves the health-conscious consumer but also provides a plant-based alternative to traditional vitamin D supplements, catering to various dietary needs. G+FLAS has established a strategic partnership with Bayer, facilitating the commercialization of its technology and enhancing its position in the agricultural market. The company is also engaged in drug research and development, utilizing its gene therapy expertise to support healthcare organizations and pharmaceutical companies. G+FLAS Life Sciences is well-positioned for growth, targeting significant market share and aiming to accelerate expansion in the U.S. and beyond.
Dr.Diary
Series B in 2022
Dr.Diary is a company that provides a comprehensive diabetes management application aimed at helping users monitor and manage their condition effectively. Founded in 2017 and based in Seoul, South Korea, the application allows users to track their blood glucose levels, exercise routines, and food intake, while offering insights on how these factors influence their health. In addition to these features, the platform includes medicine intake reminders, monthly health reports, and daily tips on diabetes management. It also facilitates communication with friends and provides personal consultation services with healthcare professionals, enhancing the overall user experience in managing diabetes.
NearthLab
Series C in 2022
Nearthlab, Inc. is a technology-focused start-up based in Seoul, South Korea, specializing in the development of autonomous drone systems primarily for the wind and renewable energy sectors. Founded by graduates of KAIST, the company leverages proprietary deep-learning algorithms to enhance safety inspections. Its flagship products include NearthWIND Pro, an autonomous drone designed for wind turbine inspections that can detect cracks and damages using AI, Zoomable, a cloud-based platform for managing and analyzing inspection data, and NearthWIND Mobile, a mobile solution for autonomous flight control. Nearthlab's AI technology allows for efficient autonomous flight in low-computing power and low-latency conditions, significantly reducing inspection times from hours to minutes. The company is supported by prominent venture capital firms in Korea, positioning it as a leader in drone technology for inspection purposes.
Y-Biologics
Venture Round in 2022
Y-Biologics Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the discovery and development of novel antibody therapeutics, particularly in the field of immuno-oncology. Established in 2007, the company has developed a unique bispecific antibody platform technology known as AliCE, which retains the structure of the parental antibody to ensure high binding affinity to cancer antigens. Additionally, Y-Biologics has created the Y-max ABL library, which comprises a diverse range of antibodies. The company also offers contract research services, further contributing to its position in the antibody drug market. Through its innovative technologies and research efforts, Y-Biologics aims to advance its portfolio of antibody drugs and strengthen its role in the global immuno-chemotherapeutic landscape.
SWING
Series B in 2022
SWING is a micro-mobility service provider.
Law&Company
Series C in 2022
Law&Company is representative legal tech company in Republic of Korea. The company provides a service called 'LawTalk(www.lawtalk.co.kr)', which is the largest online legal market place in Korea(5 times bigger then the 2nd player). Since 2016, the company invested on research about Artificial Intelligence especially on Text Mining and Machine Learning technology to analyze lawyers and client's activities in the service which helps to lawyers and clients find the right person based on their experience. Also, the company will launch document automation based service to generate legal documents starting from complaint and contract soon. The company has received more than 3 million dollars from 5 venture capital companies and many angel investors due to previous performance and upside potential in the Korean legal market.
Dealicious
Series C in 2022
Dealicious operates as an online marketplace designed to connect fashion wholesalers and retailers on a global scale. By facilitating direct access to a vast selection of quality merchandise, including clothing, bags, shoes, and accessories, Dealicious streamlines the wholesale purchasing process. The platform primarily focuses on the Dongdaemun fashion district in South Korea, renowned for its concentration of fashion manufacturing and distribution within a compact area. With approximately 11,000 registered wholesale stores, Dealicious enables retailers to browse and order from a diverse array of items, with 24,000 new products added daily. This approach eliminates the need for retailers to visit physical markets, allowing them to save valuable time and resources. Dealicious is committed to enhancing the user experience by continuously developing customer-centric services that ensure seamless access to high-quality products in the Korean fashion market.
Fount
Series C in 2021
Fount Inc. is an asset management Robo-Advisor company established in 2015 and headquartered in Seoul, South Korea. The firm specializes in providing customized financial portfolios through its advanced Robo-Advisor engine, Bluewhale, which utilizes AI technology and asset allocation theories to determine the optimal mix of assets. Fount's investing algorithm, driven by big data, assists clients in planning for various life events by promoting passive investing strategies that align with individual risk tolerance and time horizons. The company's tools enable clients to monitor financial markets and adjust their asset allocations in response to market fluctuations.
QANDA(Mathpresso)
Series C in 2021
With the mission to provide the most effective education for all, QANDA(Mathpresso) operates the world’s leading learning platform, QANDA, an AI-based learning app that allows students of all levels to receive instant answers and customized learning sources. Recognized for its technological advances, QANDA(Mathpresso) was selected as GSV Edtech 150, national representative of Google AI for Social Good APAC event in 2018, and guest speaker at AWS Public Sector Summit ASEAN in 2019. Since 2015, QANDA(Mathpresso) has raised over $105 million in total from investors including SoftBank Ventures Asia, Legend Capital, Mirae Asset Investment, GGV, and Goodwater Capital. Headquartered in Seoul, QANDA(Mathpresso) has offices in Tokyo, Hanoi, Jakarta, and Bangkok.
CLASSUM
Series A in 2021
CLASSUM Co., Ltd., founded in 2017 and based in Seoul, South Korea, operates as an interactive learning platform designed to enhance communication in educational settings. Targeting higher education and workplace learning, CLASSUM employs a user-friendly interface inspired by chat and social networking features to facilitate seamless interaction between students and instructors. The platform utilizes artificial intelligence and big data analysis to generate comprehensive class reports, providing valuable insights that help improve educational outcomes. Additionally, CLASSUM offers features such as real-time surveys, feedback mechanisms, and classroom creation tools, enabling users to engage effectively and empower their learning experiences.
Lemonex
Series C in 2021
Lemonex Inc. is a biotechnology company based in Seoul, South Korea, founded in 2013. It specializes in the development and commercialization of biotherapeutics aimed at treating cancers and other challenging diseases. The company focuses on cancer immunotherapeutics, antibody therapeutics, and gene therapeutics. Lemonex offers innovative drug delivery solutions, including DegradaBALL, which facilitates the delivery of drug candidates into cultured cells and lesions, and PANGO, a technology for the rapid screening of antiviral drugs. Additionally, Lemonex is engaged in advancing biosensor technology, enhancing the effectiveness of drug delivery methods for healthcare professionals.
Bertis
Venture Round in 2020
Bertis Inc. is a proteomics-based molecular diagnostics company focused on developing and commercializing cancer-related biomarkers for early disease detection. Founded in 2014 and based in Seongnam, South Korea, the company offers Mastocheck, a screening method for diagnosing stage 1 breast cancer. Bertis is engaged in extensive research for biomarker development aimed at the early diagnosis of various carcinomas, as well as the creation of new therapeutic markers and co-markers. Utilizing advanced bio-big data analysis technologies, the company seeks to uncover biomarkers across multiple fields by integrating proteomics, genomics, and bioinformatics. Additionally, Bertis is developing an AI-based diagnostic platform to enhance the diagnosis of cancer and cardiac diseases, thereby enabling more effective early detection and treatment options for medical practitioners.
Huinno
Series B in 2020
Huinno, Inc. is a healthcare technology company established in 2014 and headquartered in Boston, Massachusetts, with additional offices in New York and Seoul. The company specializes in developing advanced healthcare devices designed to monitor vital health data, including blood pressure, heart rate, electrocardiograms (ECG), and blood oxygen saturation levels. Utilizing proprietary wearable devices along with AI-based analytics, Huinno aims to transform the management of chronic cardiac diseases by providing continuous, real-time health monitoring with clinical-grade accuracy. Their platform includes an application and a cloud-based ecosystem that facilitates longitudinal trend analysis of patients' health metrics, medication compliance, and lifestyle habits. By offering healthcare providers a robust remote patient monitoring solution, Huinno enhances chronic disease prevention and reduces hospital readmission rates, ultimately supporting clinicians in making informed medical decisions.
Shaperon
Series C in 2020
Shaperon Inc. is a biotechnology company based in Seoul, South Korea, founded in 2008, that specializes in the research and development of innovative therapeutics targeting chronic inflammatory diseases. The company focuses on creating inflammasome inhibitors and nanobody therapeutics designed to address conditions such as atopic dermatitis, systemic inflammatory response syndrome, and neuroinflammatory diseases. Shaperon offers a variety of drug candidates, including a gel-type formulation for treating atopic dermatitis and other related inflammatory conditions. In addition to its drug development efforts, the company is involved in providing immunotherapeutic products, including single-domain neutralizing antibodies, aimed at enhancing the quality of life for patients suffering from chronic inflammation and related ailments.
Bagelcode
Series D in 2020
Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, founded in 2012. It specializes in developing mobile social casino games, allowing users to engage in popular casino experiences such as slots and poker on web and mobile platforms. The company has a diverse workforce of over 170 members from various countries, including the United States, Canada, and Israel, fostering a global talent pool to enhance its gaming offerings. With a user base exceeding 45 million worldwide, Bagelcode has experienced significant growth, reportedly expanding at an average rate of over 250% in recent years. The company is committed to continuous innovation and seeks to position itself as a leader in the global gaming industry by attracting top talent and enhancing user experiences.
Trost
Series A in 2020
Trost, operated by Humart Company Co., Ltd., specializes in mental healthcare services, offering a range of online counseling options. Founded in 2016 and headquartered in Seoul, South Korea, Trost utilizes a mobile application to facilitate consultations between users and licensed counselors, enabling effective diagnosis and treatment. In addition to counseling, the platform provides various self-analysis tests, including psychological assessments, personality evaluations, and stress-related tests. Through its employee assistance program, Trost aims to enhance mental well-being in both individual and workplace settings.
CLASSUM
Venture Round in 2019
CLASSUM Co., Ltd., founded in 2017 and based in Seoul, South Korea, operates as an interactive learning platform designed to enhance communication in educational settings. Targeting higher education and workplace learning, CLASSUM employs a user-friendly interface inspired by chat and social networking features to facilitate seamless interaction between students and instructors. The platform utilizes artificial intelligence and big data analysis to generate comprehensive class reports, providing valuable insights that help improve educational outcomes. Additionally, CLASSUM offers features such as real-time surveys, feedback mechanisms, and classroom creation tools, enabling users to engage effectively and empower their learning experiences.
Raonsecure
Venture Round in 2019
Raonsecure Co., Ltd. is an ICT security software company based in Seoul, South Korea, founded in 1998. It specializes in providing a range of security solutions for PCs and mobile devices, catering to financial institutions, government entities, and enterprises. The company's primary product is TouchEn OnePass, a biometric authentication solution designed for various applications, including payments, mobile banking, shopping, gaming networks, and fintech services. Additionally, Raonsecure offers ICT security consulting services and holds several patents in the IoT and integrated security sectors. The company is focused on advancing authentication technologies, integrating human and device security, and leveraging FIDO standards based on public key infrastructure (PKI) technology.
Huinno
Series A in 2019
Huinno, Inc. is a healthcare technology company established in 2014 and headquartered in Boston, Massachusetts, with additional offices in New York and Seoul. The company specializes in developing advanced healthcare devices designed to monitor vital health data, including blood pressure, heart rate, electrocardiograms (ECG), and blood oxygen saturation levels. Utilizing proprietary wearable devices along with AI-based analytics, Huinno aims to transform the management of chronic cardiac diseases by providing continuous, real-time health monitoring with clinical-grade accuracy. Their platform includes an application and a cloud-based ecosystem that facilitates longitudinal trend analysis of patients' health metrics, medication compliance, and lifestyle habits. By offering healthcare providers a robust remote patient monitoring solution, Huinno enhances chronic disease prevention and reduces hospital readmission rates, ultimately supporting clinicians in making informed medical decisions.
D&D Pharmatech
Series B in 2019
D&D Pharmatech Co., Ltd., established in 2014 and headquartered in Seongnam, South Korea, is a clinical-stage global biotech company specializing in developing innovative medicines. It focuses on various therapeutic areas, including neurodegenerative diseases, molecular imaging and radiotherapy, fibrotic diseases, and metabolic diseases. The company operates through disease-specific subsidiary companies guided by top-tier medical research faculty, aiming to accelerate the translation of cutting-edge research into lifesaving therapeutic products for patients. D&D Pharmatech's product pipeline is supported by its team of experts in bio-new drug research and development, manufacturing quality control, clinical development, and technology transfer. Additionally, it develops positron emission tomography (PET) imaging biomarkers through Precision Molecular Inc., a wholly-owned subsidiary, and conducts single-cell sequencing related to degenerative brain diseases via Valted Seq, Inc. The company employs technologies such as PEGylation to extend drug administration periods.
G+FLAS Life Sciences
Series C in 2019
G+FLAS Life Sciences Co., Ltd., founded in 2014 and based in Seoul, South Korea, specializes in agricultural biotechnology with a focus on genome editing applications. Utilizing advanced CRISPR-Cas technology, the company develops innovative products such as glycoengineered humanized plants, which involve the selective removal of glycosylation-related genes. A flagship product is the vitamin D3-enriched tomato, aimed at enhancing nutritional value and addressing market demand for functional foods. This product not only serves the health-conscious consumer but also provides a plant-based alternative to traditional vitamin D supplements, catering to various dietary needs. G+FLAS has established a strategic partnership with Bayer, facilitating the commercialization of its technology and enhancing its position in the agricultural market. The company is also engaged in drug research and development, utilizing its gene therapy expertise to support healthcare organizations and pharmaceutical companies. G+FLAS Life Sciences is well-positioned for growth, targeting significant market share and aiming to accelerate expansion in the U.S. and beyond.
Law&Company
Series B in 2019
Law&Company is representative legal tech company in Republic of Korea. The company provides a service called 'LawTalk(www.lawtalk.co.kr)', which is the largest online legal market place in Korea(5 times bigger then the 2nd player). Since 2016, the company invested on research about Artificial Intelligence especially on Text Mining and Machine Learning technology to analyze lawyers and client's activities in the service which helps to lawyers and clients find the right person based on their experience. Also, the company will launch document automation based service to generate legal documents starting from complaint and contract soon. The company has received more than 3 million dollars from 5 venture capital companies and many angel investors due to previous performance and upside potential in the Korean legal market.
Orum Therapeutics
Series B in 2019
Orum Therapeutics is a private biotechnology company based in Daejeon, South Korea, founded in 2016. The company specializes in the research and development of therapeutic antibodies through its innovative cell-penetrating antibody platform, Oromab™. This platform is designed to target cytosolic proteins, addressing unmet medical needs in cancer and rare genetic diseases. Orum's unique approach allows for the intracellular delivery of active antibody therapeutics or payloads, enabling the inhibition of drug targets that have been previously considered undruggable by conventional small molecules or antibody therapies. Orum's technology is adaptable to various cell types and intracellular proteins without requiring chemical modifications, aiming to develop effective treatments with improved specificity and reduced toxicity.
Wadiz
Series C in 2019
Wadiz is a prominent crowdfunding platform in South Korea that specializes in both product and equity-based crowdfunding. It connects entrepreneurs and startups with potential investors, facilitating the funding of creative projects and innovative businesses. With a user base of 6.6 million members and 10 million monthly visitors, Wadiz has become a significant player in the crowdfunding landscape, managing over 18,000 projects annually and accumulating a transaction value exceeding $1 billion. Recognized as one of Korea's top game-changing brands, the platform enhances the entrepreneurial ecosystem by providing valuable opportunities for businesses to secure funding while allowing investors to engage with emerging companies at an early stage. Wadiz is preparing to go public on the Korean stock market, further solidifying its position in the industry.
Dealicious
Series B in 2019
Dealicious operates as an online marketplace designed to connect fashion wholesalers and retailers on a global scale. By facilitating direct access to a vast selection of quality merchandise, including clothing, bags, shoes, and accessories, Dealicious streamlines the wholesale purchasing process. The platform primarily focuses on the Dongdaemun fashion district in South Korea, renowned for its concentration of fashion manufacturing and distribution within a compact area. With approximately 11,000 registered wholesale stores, Dealicious enables retailers to browse and order from a diverse array of items, with 24,000 new products added daily. This approach eliminates the need for retailers to visit physical markets, allowing them to save valuable time and resources. Dealicious is committed to enhancing the user experience by continuously developing customer-centric services that ensure seamless access to high-quality products in the Korean fashion market.
QANDA(Mathpresso)
Series A in 2018
With the mission to provide the most effective education for all, QANDA(Mathpresso) operates the world’s leading learning platform, QANDA, an AI-based learning app that allows students of all levels to receive instant answers and customized learning sources. Recognized for its technological advances, QANDA(Mathpresso) was selected as GSV Edtech 150, national representative of Google AI for Social Good APAC event in 2018, and guest speaker at AWS Public Sector Summit ASEAN in 2019. Since 2015, QANDA(Mathpresso) has raised over $105 million in total from investors including SoftBank Ventures Asia, Legend Capital, Mirae Asset Investment, GGV, and Goodwater Capital. Headquartered in Seoul, QANDA(Mathpresso) has offices in Tokyo, Hanoi, Jakarta, and Bangkok.
Vuno
Series B in 2018
Vuno Inc. is a South Korean company specializing in the development of artificial intelligence solutions for the medical field. Founded in 2014, Vuno focuses on creating AI-based products that assist healthcare professionals in analyzing medical data and diagnosing diseases. Its notable offerings include BoneAge, which assesses bone age, DeepBrain, designed for the analysis of neurodegenerative diseases, and a chest X-ray diagnostic support system. Additionally, Vuno provides fundus AI for eye abnormalities and LungCT AI for detecting and reporting pulmonary nodules. The company serves a range of clients, including Asan Medical Center and HYUNDAI, and also offers VunoMed, a platform for analyzing various medical data types, including videos, ECGs, and electronic medical records.
Wishket
Venture Round in 2018
Wishket Co., Ltd. is an IT outsourcing platform based in Seoul, South Korea, established in 2012. It facilitates the connection between companies and freelancers by allowing them to post projects and search for job opportunities online. The platform offers a secure and cost-effective way for companies to find suitable freelancers for development work. By enabling companies to post projects and receive responses from freelancers, Wishket streamlines the outsourcing process. Additionally, it provides freelancers with access to new projects and opportunities. The platform is designed to minimize transaction costs and trust issues commonly associated with IT project outsourcing, thanks to its private application and escrow system, which enhances the overall efficiency of the contracting process.
Bagelcode
Series C in 2018
Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, founded in 2012. It specializes in developing mobile social casino games, allowing users to engage in popular casino experiences such as slots and poker on web and mobile platforms. The company has a diverse workforce of over 170 members from various countries, including the United States, Canada, and Israel, fostering a global talent pool to enhance its gaming offerings. With a user base exceeding 45 million worldwide, Bagelcode has experienced significant growth, reportedly expanding at an average rate of over 250% in recent years. The company is committed to continuous innovation and seeks to position itself as a leader in the global gaming industry by attracting top talent and enhancing user experiences.
Life Semantics
Corporate Round in 2018
Life Semantics (라이프시맨틱스) is a Korean specialty engineering company focused on developing software platforms and systems for the medical industry. It develops Hospital Information Systems (HIS) and semantic web technology for application in the area of life sciences. The company looks to resolve common problems faced by healthcare facilities and researchers by providing automation software. HIS is a fully integrated information system providing healthcare organizations with a full suite of tools for improved hospital management, clinical tasks, and patient administration.
Syntekabio
Series B in 2018
Syntekabio, Inc. is a bioinformatics company based in Daejeon, South Korea, founded in 2009. It specializes in managing and analyzing genomic data through advanced algorithms and artificial intelligence. The company develops personal genome maps that serve as comprehensive resources for disease prevention and tailored drug development. Additionally, it offers genome data integration services and operates a supercomputer known as MAHA, which enhances data processing efficiency for genome-based diagnostics. Syntekabio also focuses on collecting and integrating decrypted whole genome data for various applications, including the analysis of rare diseases and genetic relationships, by sequencing blood samples from diverse populations worldwide.
D&D Pharmatech
Series A in 2018
D&D Pharmatech Co., Ltd., established in 2014 and headquartered in Seongnam, South Korea, is a clinical-stage global biotech company specializing in developing innovative medicines. It focuses on various therapeutic areas, including neurodegenerative diseases, molecular imaging and radiotherapy, fibrotic diseases, and metabolic diseases. The company operates through disease-specific subsidiary companies guided by top-tier medical research faculty, aiming to accelerate the translation of cutting-edge research into lifesaving therapeutic products for patients. D&D Pharmatech's product pipeline is supported by its team of experts in bio-new drug research and development, manufacturing quality control, clinical development, and technology transfer. Additionally, it develops positron emission tomography (PET) imaging biomarkers through Precision Molecular Inc., a wholly-owned subsidiary, and conducts single-cell sequencing related to degenerative brain diseases via Valted Seq, Inc. The company employs technologies such as PEGylation to extend drug administration periods.
Wadiz
Series B in 2017
Wadiz is a prominent crowdfunding platform in South Korea that specializes in both product and equity-based crowdfunding. It connects entrepreneurs and startups with potential investors, facilitating the funding of creative projects and innovative businesses. With a user base of 6.6 million members and 10 million monthly visitors, Wadiz has become a significant player in the crowdfunding landscape, managing over 18,000 projects annually and accumulating a transaction value exceeding $1 billion. Recognized as one of Korea's top game-changing brands, the platform enhances the entrepreneurial ecosystem by providing valuable opportunities for businesses to secure funding while allowing investors to engage with emerging companies at an early stage. Wadiz is preparing to go public on the Korean stock market, further solidifying its position in the industry.
Wadiz
Series A in 2017
Wadiz is a prominent crowdfunding platform in South Korea that specializes in both product and equity-based crowdfunding. It connects entrepreneurs and startups with potential investors, facilitating the funding of creative projects and innovative businesses. With a user base of 6.6 million members and 10 million monthly visitors, Wadiz has become a significant player in the crowdfunding landscape, managing over 18,000 projects annually and accumulating a transaction value exceeding $1 billion. Recognized as one of Korea's top game-changing brands, the platform enhances the entrepreneurial ecosystem by providing valuable opportunities for businesses to secure funding while allowing investors to engage with emerging companies at an early stage. Wadiz is preparing to go public on the Korean stock market, further solidifying its position in the industry.
Bagelcode
Series B in 2017
Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, founded in 2012. It specializes in developing mobile social casino games, allowing users to engage in popular casino experiences such as slots and poker on web and mobile platforms. The company has a diverse workforce of over 170 members from various countries, including the United States, Canada, and Israel, fostering a global talent pool to enhance its gaming offerings. With a user base exceeding 45 million worldwide, Bagelcode has experienced significant growth, reportedly expanding at an average rate of over 250% in recent years. The company is committed to continuous innovation and seeks to position itself as a leader in the global gaming industry by attracting top talent and enhancing user experiences.
Vuno
Series A in 2016
Vuno Inc. is a South Korean company specializing in the development of artificial intelligence solutions for the medical field. Founded in 2014, Vuno focuses on creating AI-based products that assist healthcare professionals in analyzing medical data and diagnosing diseases. Its notable offerings include BoneAge, which assesses bone age, DeepBrain, designed for the analysis of neurodegenerative diseases, and a chest X-ray diagnostic support system. Additionally, Vuno provides fundus AI for eye abnormalities and LungCT AI for detecting and reporting pulmonary nodules. The company serves a range of clients, including Asan Medical Center and HYUNDAI, and also offers VunoMed, a platform for analyzing various medical data types, including videos, ECGs, and electronic medical records.
Fount
Series A in 2016
Fount Inc. is an asset management Robo-Advisor company established in 2015 and headquartered in Seoul, South Korea. The firm specializes in providing customized financial portfolios through its advanced Robo-Advisor engine, Bluewhale, which utilizes AI technology and asset allocation theories to determine the optimal mix of assets. Fount's investing algorithm, driven by big data, assists clients in planning for various life events by promoting passive investing strategies that align with individual risk tolerance and time horizons. The company's tools enable clients to monitor financial markets and adjust their asset allocations in response to market fluctuations.
Stripes
Series B in 2015
Stripes is a Korea-based apparel company established in January 2013, specializing in the design and manufacture of men's clothing. The company offers a diverse collection that includes both trendy and everyday essentials such as t-shirts, shirts, and suits. Stripes also provides personalized styling services, allowing customers to customize their clothing for a perfect fit. The company's online platform facilitates convenient shopping, enabling consumers to purchase apparel from the comfort of their homes. In addition to individual sales, Stripes offers professional style consulting and customized group clothing options for businesses, helping male customers access quality apparel and accessories at competitive prices.
Wishket
Series A in 2015
Wishket Co., Ltd. is an IT outsourcing platform based in Seoul, South Korea, established in 2012. It facilitates the connection between companies and freelancers by allowing them to post projects and search for job opportunities online. The platform offers a secure and cost-effective way for companies to find suitable freelancers for development work. By enabling companies to post projects and receive responses from freelancers, Wishket streamlines the outsourcing process. Additionally, it provides freelancers with access to new projects and opportunities. The platform is designed to minimize transaction costs and trust issues commonly associated with IT project outsourcing, thanks to its private application and escrow system, which enhances the overall efficiency of the contracting process.
NBT
Series B in 2015
NBT Partners is a South Korean company established in 2012, specializing in mobile and online platform development services. The company offers a range of products, including Cache Slides, an application designed to verify information during shopping activities through a slide unlock screen, and Baobab Class, an online platform that delivers personalized educational content. Additionally, NBT provides a mobile application that features a customized accumulation system and leverages knowledge-based technology to cater to users' preferences.
Parking Square
Series A in 2015
Parking Square Inc provides smart mobile solutions and services for parking services in Korea. It provides solutions for real time parking services involving booking and discounts. Parking Square Inc provides an application known as Park Here, which allows users to find, locate, and book parking spaces at discounted rates. Parking Square is available as an iOS and Android app. It also enables garage owners and operators to promote and rent out their idle parking space. The company was established on May 7, 2013, based in Seoul, Korea.
Stripes
Series A in 2014
Stripes is a Korea-based apparel company established in January 2013, specializing in the design and manufacture of men's clothing. The company offers a diverse collection that includes both trendy and everyday essentials such as t-shirts, shirts, and suits. Stripes also provides personalized styling services, allowing customers to customize their clothing for a perfect fit. The company's online platform facilitates convenient shopping, enabling consumers to purchase apparel from the comfort of their homes. In addition to individual sales, Stripes offers professional style consulting and customized group clothing options for businesses, helping male customers access quality apparel and accessories at competitive prices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.